Chief Business Officer
Vaccine Industry · 2024-10-04
Framework Evaluation
2 of 3 criteria metThe AAO agreed with the Director that the Petitioner established a leading or critical role for organizations or establishments with a distinguished reputation, satisfying this criterion.
The AAO concluded that the Petitioner established, by a preponderance of the evidence, that he satisfies the criterion pertaining to a high salary or other significantly high remuneration.
The Director concluded the Petitioner made original contributions but did not establish their major significance, viewing them as 'scientific contributions'. The AAO found this was an incorrect standard, as the Petitioner's expertise is in law and business, not science, and remanded for re-evaluation under the proper business context.
The Petitioner's participation in annual meetings with NIAID/NIH was not considered membership in a qualifying association, as participation was based on rank, not outstanding achievement. The argument that typical associations don't exist for his niche field was rejected.
Submitted press releases and articles included brief quotations but did not substantially discuss the Petitioner's work. The Director found the materials were not about the petitioner and his work, and the Petitioner did not prove the publications were 'major' or that the criterion didn't readily apply to his 'behind-the-scenes' work.
Why This Petition Was Remanded
Evidence
- leading or critical role for distinguished organizations or establishments
- high remuneration for services
- participation in senior leaders meetings with NIAID/NIH
- press releases and articles mentioning presence at news conferences
- quotations in articles about legal disputes
- documentation concerning vaccine licensing agreements
- documentation concerning establishment of manufacturing facilities
Similar Cases
Chief Executive Officer (CEO)
Marketing and Advertising · Nigeria
Chief Financial Officer (CFO)
Financial Services · Canada
Chief Executive Officer (CEO)
Food and Beverage · Colombia
Chief Executive Officer (CEO)
Fintech · Ukraine
Frequently Asked Questions
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-10-04.
Browse all casesAt a Glance
EB-1A Case Data
Scraped Case Data
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist